WitrynaImmune-related adverse events. Immune checkpoint inhibitors (e.g. ipilimumab, pembrolizumab, nivolumab, avelumab, atezolizumab) are forms of immunotherapy which work by stimulating the immune system (T-cells) to fight cancer and have been associated with substantial improvements in the prognosis of the disease. ... WitrynaImmunotherapy-related renal toxicity was associated with an increase in renal size coincident with acute renal dysfunction. ... who received immune-checkpoint inhibitors …
MANAGEMENT OF IMMUNE-RELATED ADVERSE EVENTS IN …
Sixteen patients developed AKI while on CPIs and required renal biopsies over the past 10 years at our institution. The characteristics of these patients, urine findings, AKI category, and associated renal pathology are summarized in Table 1. Most cases identified were white men (1 case was a Hispanic man, and 4 … Zobacz więcej The median time to development of AKI after starting a CPI was 14 weeks (range: 6–56 weeks). However, AKI occurred within 9 weeks with the use of the CTLA-4 inhibitor … Zobacz więcej IgA nephropathy developed in a patient receiving the combination therapy of ipilimumab and nivolumab and in a patient receiving pembrolizumab. Both patients had … Zobacz więcej Acute focal segmental necrotizing pauci -immune glomerulonephritis was noted in 3 cases, with nivolumab in 1 case, tremelimumab in 1 case, and nivolumab combined with ipilimumab, in 1 case. The patient on … Zobacz więcej Witryna1 mar 2024 · The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that may be caused by an irAE and should trigger further … hillman therapy
Immunotherapy of thymic epithelial tumors: molecular …
Witryna31 maj 2024 · Kidney biopsy demonstrated acute tubulointerstitial nephritis (ATIN). This case highlights the importance of recognizing acute tubulointerstitial nephritis as a … Witryna1 lis 2024 · munotherapy because of AE, AE-related morbidity or mortality, organ dysfunction based on organ system affected, required treatment because of immune … Witryna31 paź 2024 · In the 1,016 patients the analysis, 169 patients (17%) experienced AKI, 82 patients (8%) experienced sustained AKI, and 30 patients (3%) had potential immune checkpoint inhibitor–related AKI. hillman state park camping